Granulomatous myositis associated with antithyroglobulin and antithyroid peroxidase antibodies: an analogy to Hashimoto's encephalitis?
Fischer
Dirk
D
Schröder
Rolf
R
D000906:Antibodies / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D004660:Encephalitis / Q000473:pathology; D005805:Genes, MHC Class I; D006099:Granuloma / Q000276:immunology / Q000473:pathology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use; D007150:Immunohistochemistry; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology; D009220:Myositis / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology* / Q000503:physiopathology; D013961:Thyroid Gland / Q000276:immunology*; D013967:Thyroiditis, Autoimmune / Q000473:pathology
D000906:Antibodies; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; C006606:anti-thyroglobulin; D003520:Cyclophosphamide